OraSure Technologies - 32 Year Stock Price History | OSUR
Historical daily share price chart and data for OraSure Technologies since 1992 adjusted for splits and dividends. The latest closing stock price for OraSure Technologies as of April 26, 2024 is 5.32.
- The all-time high OraSure Technologies stock closing price was 24.88 on December 23, 1994.
- The OraSure Technologies 52-week high stock price is 8.45, which is 58.8% above the current share price.
- The OraSure Technologies 52-week low stock price is 4.38, which is 17.7% below the current share price.
- The average OraSure Technologies stock price for the last 52 weeks is 6.26.
| OraSure Technologies Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2024 | 6.8598 | 8.2800 | 8.2800 | 5.2200 | 5.3200 | -35.12% |
| 2023 | 5.9551 | 4.7900 | 8.3500 | 4.4000 | 8.2000 | 70.12% |
| 2022 | 5.2737 | 8.6600 | 9.3300 | 2.7100 | 4.8200 | -44.53% |
| 2021 | 10.6955 | 11.2100 | 15.4200 | 8.3000 | 8.6900 | -17.90% |
| 2020 | 11.7626 | 7.8900 | 19.5800 | 5.5700 | 10.5850 | 31.82% |
| 2019 | 9.1443 | 11.6700 | 13.0900 | 6.5700 | 8.0300 | -31.25% |
| 2018 | 16.3639 | 19.2900 | 22.0400 | 10.5300 | 11.6800 | -38.07% |
| 2017 | 15.7649 | 8.7900 | 22.8100 | 8.4800 | 18.8600 | 114.81% |
| 2016 | 7.2931 | 6.3500 | 9.3700 | 5.1800 | 8.7800 | 36.34% |
| 2015 | 6.3313 | 9.9500 | 10.5200 | 4.4400 | 6.4400 | -36.49% |
| 2014 | 7.7533 | 6.4700 | 10.5300 | 5.5300 | 10.1400 | 61.21% |
| 2013 | 5.4950 | 7.2500 | 7.3700 | 3.7900 | 6.2900 | -12.40% |
| 2012 | 10.0560 | 9.5100 | 13.3800 | 6.6900 | 7.1800 | -21.19% |
| 2011 | 8.0305 | 6.0100 | 9.9900 | 6.0100 | 9.1100 | 58.43% |
| 2010 | 4.8892 | 5.2900 | 6.7700 | 3.2500 | 5.7500 | 13.19% |
| 2009 | 3.1958 | 3.6600 | 5.1900 | 2.2500 | 5.0800 | 38.04% |
| 2008 | 5.3908 | 8.7200 | 9.1100 | 2.4300 | 3.6800 | -58.61% |
| 2007 | 8.5124 | 8.1500 | 10.5200 | 7.0400 | 8.8900 | 7.63% |
| 2006 | 8.8518 | 9.1200 | 11.5000 | 6.2500 | 8.2600 | -6.35% |
| 2005 | 8.8830 | 6.6000 | 13.9400 | 5.4300 | 8.8200 | 31.25% |
| 2004 | 7.6589 | 7.9200 | 10.5000 | 5.2000 | 6.7200 | -15.58% |
| 2003 | 7.7209 | 5.6400 | 10.7900 | 5.3800 | 7.9600 | 46.06% |
| 2002 | 5.9586 | 12.2000 | 12.2000 | 3.6500 | 5.4500 | -55.14% |
| 2001 | 10.1882 | 7.5310 | 14.7400 | 6.5000 | 12.1500 | 47.27% |
| 2000 | 10.8315 | 6.4400 | 17.0000 | 5.8750 | 8.2500 | 26.92% |
| 1999 | 5.6113 | 6.0000 | 7.8800 | 4.0000 | 6.5000 | 10.73% |
| 1998 | 5.3131 | 5.3800 | 6.8800 | 3.0000 | 5.8700 | 17.40% |
| 1997 | 8.7378 | 12.1200 | 16.2500 | 4.5000 | 5.0000 | -56.52% |
| 1996 | 15.5263 | 15.2500 | 21.5000 | 11.1200 | 11.5000 | -30.30% |
| 1995 | 15.5519 | 21.2500 | 21.2500 | 9.8800 | 16.5000 | -22.83% |
| 1994 | 18.1950 | 20.5000 | 24.8800 | 14.0000 | 21.3800 | 4.91% |
| 1993 | 19.4374 | 19.1200 | 23.6200 | 16.2500 | 20.3800 | 13.22% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.402B | $0.405B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $185.422B | 24.34 |
| Stryker (SYK) | United States | $128.275B | 31.81 |
| Boston Scientific (BSX) | United States | $107.479B | 34.23 |
| Medtronic (MDT) | Ireland | $105.230B | 14.90 |
| EssilorLuxottica (ESLOY) | France | $98.467B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.075B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.356B | 30.00 |
| ResMed (RMD) | United States | $26.979B | 25.30 |
| Terumo (TRUMY) | Japan | $24.775B | 34.99 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.604B | 15.84 |
| Baxter (BAX) | United States | $20.430B | 14.90 |
| Koninklijke Philips (PHG) | Netherlands | $19.242B | 15.35 |
| Insulet (PODD) | United States | $11.496B | 60.36 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.440B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.860B | 23.42 |
| BellRing Brands (BRBR) | United States | $7.238B | 38.92 |
| Lantheus Holdings (LNTH) | United States | $4.470B | 11.54 |
| Haemonetics (HAE) | United States | $4.452B | 22.77 |
| Perrigo (PRGO) | Ireland | $4.238B | 12.12 |
| GN Store Nord (GNNDY) | Denmark | $3.889B | 25.18 |
| Prestige Consumer Healthcare (PBH) | United States | $3.482B | 16.47 |
| Envista Holdings (NVST) | United States | $3.441B | 13.09 |
| QuidelOrtho (QDEL) | United States | $2.654B | 9.63 |
| Neogen (NEOG) | United States | $2.591B | 24.92 |
| Green Thumb Industries (GTBIF) | United States | $2.482B | 78.67 |
| ICU Medical (ICUI) | United States | $2.303B | 17.19 |
| TG Therapeutics (TGTX) | United States | $2.150B | 695.50 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.906B | 0.00 |
| Owens & Minor (OMI) | United States | $1.848B | 17.74 |
| Agios Pharmaceuticals (AGIO) | United States | $1.780B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.617B | 0.00 |
| InMode (INMD) | Israel | $1.429B | 7.40 |
| LeMaitre Vascular (LMAT) | United States | $1.414B | 46.66 |
| National Vision Holdings (EYE) | United States | $1.399B | 43.58 |
| AdaptHealth (AHCO) | United States | $1.273B | 9.58 |
| Warby Parker (WRBY) | United States | $1.254B | 0.00 |
| AtriCure (ATRC) | United States | $1.094B | 0.00 |
| MacroGenics (MGNX) | United States | $0.899B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.872B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.764B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.686B | 14.82 |
| Cresco Labs (CRLBF) | United States | $0.674B | 0.00 |
| Evolus (EOLS) | United States | $0.664B | 0.00 |
| Jin Medical (ZJYL) | China | $0.608B | 0.00 |
| Quanterix (QTRX) | United States | $0.596B | 0.00 |
| Valneva SE (VALN) | France | $0.526B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.504B | 10.91 |
| PetIQ (PETQ) | United States | $0.480B | 17.93 |
| TerrAscend (TSNDF) | Canada | $0.462B | 0.00 |
| ZimVie (ZIMV) | United States | $0.421B | 25.80 |
| Biote (BTMD) | United States | $0.416B | 3.96 |
| Surmodics (SRDX) | United States | $0.373B | 40.26 |
| Aurora Cannabis (ACB) | Canada | $0.366B | 0.00 |
| Zynex (ZYXI) | United States | $0.352B | 40.52 |
| Viemed Healthcare (VMD) | United States | $0.310B | 30.81 |
| Cerus (CERS) | United States | $0.308B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.266B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.238B | 14.73 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.178B | 0.00 |
| Omeros (OMER) | United States | $0.177B | 0.00 |
| Veru (VERU) | United States | $0.177B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
| High Tide (HITI) | Canada | $0.161B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.156B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.141B | 70.99 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.74 |
| Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
| InterCure (INCR) | Israel | $0.120B | 20.31 |
| Fonar (FONR) | United States | $0.107B | 9.16 |
| MariMed (MRMD) | United States | $0.100B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
| Safety Shot (SHOT) | United States | $0.082B | 0.00 |
| Brainsway (BWAY) | Israel | $0.080B | 0.00 |
| Chimerix (CMRX) | United States | $0.079B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.059B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.59 |
| Apyx Medical (APYX) | United States | $0.051B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.95 |
| Bright Green (BGXX) | United States | $0.035B | 0.00 |
| Modular Medical (MODD) | United States | $0.033B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 74.09 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |